Baudax Bio Inc. (BXRX)
NASDAQ: BXRX
· Real-Time Price · USD
0.02
-0.00 (-1.48%)
At close: Feb 29, 2024, 9:53 PM
Baudax Bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -25.83M | -53.14M | -53.37M | -58.8M | -20.11M | -7.87M | -15.67M | -19.77M | -66.25M | -37.6M | -52.71M |
Depreciation & Amortization | 240K | 792K | 1.48M | 2.16M | 2.75M | 2.75M | 2.77M | 2.82M | 2.86M | 2.92M | 2.96M |
Stock-Based Compensation | 871K | 932K | 1.07M | 1.4M | 1.83M | 2.44M | 3.01M | 4.79M | 6.04M | 7.61M | 9.01M |
Other Working Capital | -1.05M | -195K | 973K | 1.44M | 777K | 126K | -139K | 921K | 613K | 9.7M | 7.91M |
Other Non-Cash Items | 7.46M | 31.36M | 32.71M | 27.38M | -20.99M | -40.62M | -38.07M | -32.41M | -1.55M | -22.8M | -22.78M |
Deferred Income Tax | -834K | 2.8M | n/a | n/a | -11K | -17K | -1.63M | -1.61M | 12.27M | 1.09M | 15.37M |
Change in Working Capital | 3.78M | 1.48M | -1.44M | 62K | -120K | -2.02M | 1.42M | -3.08M | -4.63M | -1.72M | -3.61M |
Operating Cash Flow | -14.31M | -15.78M | -19.55M | -27.79M | -36.66M | -45.34M | -48.17M | -49.27M | -51.26M | -50.49M | -51.75M |
Capital Expenditures | 40K | 20K | n/a | -20K | -187K | -167K | -150K | -203K | -408K | -715K | -712K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | -7.49M | -12.15M | -19.64M | -19.64M | -12.15M | -7.5M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 10.15M | 10.15M | 10.15M | 10.15M | n/a | n/a | n/a |
Other Investing Acitivies | 121K | 142K | n/a | n/a | n/a | 9.5M | 9.5M | 9.5M | 9.5M | n/a | n/a |
Investing Cash Flow | 161K | 162K | n/a | -20K | 9.96M | 11.99M | 7.35M | -194K | -10.55M | -12.86M | -8.21M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -2K | -3K | -3K | -1K | -14K | -13K | -13K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | -1K | -1K | -1K | -1K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 8.9M | 11.85M | 11.83M | 17.18M | 17.53M | 13.13M | 21.65M | 35.01M | 51.97M | 49.36M | 52.36M |
Financial Cash Flow | 8.9M | 11.85M | 11.83M | 17.18M | 17.53M | 13.13M | 21.65M | 35.01M | 51.97M | 49.36M | 52.36M |
Net Cash Flow | -5.28M | -3.79M | -7.72M | -10.63M | -9.13M | -20.2M | -19.16M | -14.45M | -9.84M | -14M | -7.59M |
Free Cash Flow | -14.27M | -15.76M | -19.55M | -27.81M | -36.84M | -45.5M | -48.32M | -49.47M | -51.66M | -51.21M | -52.46M |